<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7491483\results\search\disease\results.xml">
  <result pre="pandemic on the lifestyle and management of patients with homozygous" exact="familial" post="hypercholesterolemia KayikciogluMeralMDâˆ—[], TokgozogluLaleMD[], TuncelOzlem KumanMDPirildarSebnemMD[], CanLeventMD[], âˆ—Corresponding author. Ege"/>
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="resource centre remains active. Graphical abstract Highlights â€¢Patients with homozygous" exact="familial" post="hypercholesterolemia (HoFH) have increased cardiovascular risk. â€¢Coronavirus disease 2019"/>
  <result pre="abstract Highlights â€¢Patients with homozygous familial hypercholesterolemia (HoFH) have increased" exact="cardiovascular" post="risk. â€¢Coronavirus disease 2019 (COVID-19) pandemic affected healthy life"/>
  <result pre="with homozygous familial hypercholesterolemia (HoFH) have increased cardiovascular risk. â€¢Coronavirus" exact="disease" post="2019 (COVID-19) pandemic affected healthy life behaviors and anxiety"/>
  <result pre="â€¢Coronavirus disease 2019 (COVID-19) pandemic affected healthy life behaviors and" exact="anxiety" post="of patients with HoFH. â€¢Fear of COVID-19 leads to"/>
  <result pre="is disrupted during the pandemic. The sudden outbreak of coronavirus" exact="disease" post="2019 (COVID-19) caused unprecedented pressure on the community and"/>
  <result pre="pandemic also had a negative impact on noninfected patients with" exact="chronic" post="and rare diseases.1 Severe restriction of daily life, including"/>
  <result pre="negative impact on noninfected patients with chronic and rare diseases.1" exact="Severe" post="restriction of daily life, including lockdown, to prevent the"/>
  <result pre="management and access to treatments of patients with these disorders." exact="Homozygous" post="familial hypercholesterolemia (HoFH) is a rare chronic genetic disease"/>
  <result pre="and access to treatments of patients with these disorders. Homozygous" exact="familial" post="hypercholesterolemia (HoFH) is a rare chronic genetic disease with"/>
  <result pre="with these disorders. Homozygous familial hypercholesterolemia (HoFH) is a rare" exact="chronic" post="genetic disease with very high low-density lipoprotein cholesterol (LDL-C)"/>
  <result pre="disorders. Homozygous familial hypercholesterolemia (HoFH) is a rare chronic genetic" exact="disease" post="with very high low-density lipoprotein cholesterol (LDL-C) levels leading"/>
  <result pre="survival of patients with HoFH by delaying the progression of" exact="atherosclerosis" post="and decreasing the incidence of major cardiovascular (CV) events.2,3"/>
  <result pre="the progression of atherosclerosis and decreasing the incidence of major" exact="cardiovascular" post="(CV) events.2,3 Regular LDL apheresis (LA), in combination with"/>
  <result pre="patients.2, 3, 4 Moreover, because of their lifelong risk of" exact="CV disease," post="at every age, patients with HoFH may have an"/>
  <result pre="to host cells in case of high cholesterol levels.5 Previous" exact="viral" post="epidemics have shown that CV events significantly increase during"/>
  <result pre="outbreak and the ensuing quarantine measures on the heart-healthy lifestyle," exact="anxiety" post="level, and management of patients with HoFH. Inclusion criteria"/>
  <result pre="impact of COVID-19 pandemic on management, healthy lifestyle habits, and" exact="anxiety" post="levels. Participants were requested to rate their anxiety level"/>
  <result pre="habits, and anxiety levels. Participants were requested to rate their" exact="anxiety" post="level during this pandemic, between 1 and 10 (1"/>
  <result pre="questions and results of the survey. TableÂ 1 Study populationsâ€™" exact="anxiety" post="level, attitude and behavioral changes since the emergence of"/>
  <result pre="(%) - 9 (26.5) 2 (14.3) 0 2 (14.3) FH," exact="familial" post="hypercholesterolemia; LA, LDL apheresis; LLT, lipid-lowering therapy; SD, standard"/>
  <result pre="LA, LDL apheresis; LLT, lipid-lowering therapy; SD, standard deviation. âˆ—The" exact="anxiety" post="level for all samples has a skewed distribution; the"/>
  <result pre="6Â years. Overall, 70.6% of the cases had had documented" exact="CV disease" post="(including aortic stenosis). All patients were on maximal doses"/>
  <result pre="years. Overall, 70.6% of the cases had had documented CV" exact="disease" post="(including aortic stenosis). All patients were on maximal doses"/>
  <result pre="on top of LA. One patient who had a severe" exact="recurrent" post="increase in LDL-C levels after liver transplantation was on"/>
  <result pre="and 23.5% reported an increased level of exercise. Increase in" exact="anxiety" post="Almost 62% of the patients reported an increase in"/>
  <result pre="Almost 62% of the patients reported an increase in their" exact="anxiety" post="level during the outbreak. The median anxiety level was"/>
  <result pre="increase in their anxiety level during the outbreak. The median" exact="anxiety" post="level was 5 (minÂ =Â 0, maxÂ =Â 9)."/>
  <result pre="level was 5 (minÂ =Â 0, maxÂ =Â 9). The" exact="anxiety" post="level was not associated with age, gender, history of"/>
  <result pre="anxiety level was not associated with age, gender, history of" exact="CV disease," post="or duration of the disease. Having a previous psychiatric"/>
  <result pre="20%) did not have any impact on lifestyle measure changes," exact="anxiety" post="level and was not associated with age. Awareness of"/>
  <result pre="that HoFH would not lead to a worse prognosis reported" exact="lower" post="anxiety level than the patients who perceived themselves vulnerable"/>
  <result pre="HoFH would not lead to a worse prognosis reported lower" exact="anxiety" post="level than the patients who perceived themselves vulnerable (PÂ"/>
  <result pre="picture was the same for those with a history of" exact="CV disease;" post="67% reported that they would avoid going to a"/>
  <result pre="a hospital even if they had a complaint like a" exact="chest" post="pain, which might be a sign of a fatal"/>
  <result pre="chest pain, which might be a sign of a fatal" exact="heart" post="attack. Avoidance of seeking medical care was not associated"/>
  <result pre="Avoidance of seeking medical care was not associated with the" exact="anxiety" post="level, the duration of follow-up in the center, and"/>
  <result pre="cause of the reduced and late number of admissions of" exact="acute" post="coronary syndromes, reported during the COVID-19 breakout.8 Management of"/>
  <result pre="the Ministry of Health enabled patients to access drugs for" exact="chronic" post="diseases from pharmacies without new prescriptions for 6Â months."/>
  <result pre="precaution to avoid interruption of pharmacotherapy in the management of" exact="chronic" post="diseases during the pandemic. However, access to LA, which"/>
  <result pre="also revealed that patients receiving additional new-generation LLT had a" exact="lower" post="anxiety level than nonusers (85.7% vs 42.9%) (TableÂ 1)."/>
  <result pre="revealed that patients receiving additional new-generation LLT had a lower" exact="anxiety" post="level than nonusers (85.7% vs 42.9%) (TableÂ 1). Nonusers"/>
  <result pre="diet than users probably reflecting both a high-risk perception and/or" exact="anxiety" post="due to no access to an effective LLT modality."/>
  <result pre="lowering LDL-C in patients with HoFH, it is a hospital-based" exact="chronic" post="treatment procedure. Therefore, effective pharmacotherapies are needed to avoid"/>
  <result pre="pandemic on patients with HoFH? Gradual quarantine measures, economic concerns," exact="emotional" post="load, and the fear of contracting the coronavirus are"/>
  <result pre="contracting the coronavirus are probably the explanation of the increased" exact="anxiety" post="and disruption of heart-healthy lifestyle changes observed in our"/>
  <result pre="a sedentary lifestyle and enormously increased screen time decreased energy" exact="consumption" post="meanwhile increasing the difficulty to access fresh fruit and"/>
  <result pre="with the patients and providing the necessary information, as optimum" exact="anxiety" post="and high perceived risk were correlated with taking some"/>
  <result pre="new campaign organized by the patient organizations FH Europe, Global" exact="Heart" post="Hub and supported by the European Atherosclerosis Society encouraging"/>
  <result pre="medical help has started. This campaign is called â€˜When your" exact="heart" post="says so, #JustGoâ€™ and has been reached by 80,000,000"/>
  <result pre="expected. References References 1DuR.H.LiangL.R.YangC.Q.Predictors of mortality for patients with COVID-19" exact="pneumonia" post="caused by SARS-CoV-2: a prospective cohort studyEur Respir J552020200052432269088"/>
  <result pre="International Lipid Expert Panel (ILEP)Brief recommendations on the management of" exact="adult" post="patients with familial hypercholesterolemia during the COVID-19 pandemicPharmacol Res158202010489132389859"/>
  <result pre="Panel (ILEP)Brief recommendations on the management of adult patients with" exact="familial" post="hypercholesterolemia during the COVID-19 pandemicPharmacol Res158202010489132389859 3KayikciogluM.TokgozogluL.YilmazM.A nation-wide survey"/>
  <result pre="COVID-19 pandemicPharmacol Res158202010489132389859 3KayikciogluM.TokgozogluL.YilmazM.A nation-wide survey of patients with homozygous" exact="familial" post="hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)Atherosclerosis2702018424829407887"/>
  <result pre="phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)Atherosclerosis2702018424829407887 4DuffyE.Y.Cainzos-AchiricaM.MichosE.D.Primary and" exact="secondary" post="prevention of cardiovascular disease in the era of the"/>
  <result pre="in Turkey (A-HIT 1 registry)Atherosclerosis2702018424829407887 4DuffyE.Y.Cainzos-AchiricaM.MichosE.D.Primary and secondary prevention of" exact="cardiovascular disease" post="in the era of the coronavirus pandemicCirculation14120201943194532310675 5WangH.YuanZ.PavelM.A.HansenS.B.The role"/>
  <result pre="Turkey (A-HIT 1 registry)Atherosclerosis2702018424829407887 4DuffyE.Y.Cainzos-AchiricaM.MichosE.D.Primary and secondary prevention of cardiovascular" exact="disease" post="in the era of the coronavirus pandemicCirculation14120201943194532310675 5WangH.YuanZ.PavelM.A.HansenS.B.The role"/>
  <result pre="role of high cholesterol in age-related COVID19 lethalitybioRxiv202010.1101/2020.05.09.086249 6NguyenJ.L.YangW.ItoK.MatteT.D.ShamanJ.KinneyP.L.Seasonal influenza" exact="infections" post="and cardiovascular disease mortalityJAMA Cardiol1201627428127438105 7A study of inclisiran"/>
  <result pre="high cholesterol in age-related COVID19 lethalitybioRxiv202010.1101/2020.05.09.086249 6NguyenJ.L.YangW.ItoK.MatteT.D.ShamanJ.KinneyP.L.Seasonal influenza infections and" exact="cardiovascular disease" post="mortalityJAMA Cardiol1201627428127438105 7A study of inclisiran in participants with"/>
  <result pre="cholesterol in age-related COVID19 lethalitybioRxiv202010.1101/2020.05.09.086249 6NguyenJ.L.YangW.ItoK.MatteT.D.ShamanJ.KinneyP.L.Seasonal influenza infections and cardiovascular" exact="disease" post="mortalityJAMA Cardiol1201627428127438105 7A study of inclisiran in participants with"/>
  <result pre="mortalityJAMA Cardiol1201627428127438105 7A study of inclisiran in participants with homozygous" exact="familial" post="hypercholesterolemia (HoFH) (ORION-5)Available at:https://clinicaltrials.gov/ct2/show/NCT03851705 8LantelmeP.Couray TargeS.MetralP.Worrying decrease in hospital"/>
  <result pre="(HoFH) (ORION-5)Available at:https://clinicaltrials.gov/ct2/show/NCT03851705 8LantelmeP.Couray TargeS.MetralP.Worrying decrease in hospital admissions for" exact="myocardial infarction" post="during the COVID-19 pandemicArch Cardiovasc Dis1136-7202044344732636131 9BangaloreS.BreaznaA.DeMiccoD.A.WunC.C.MesserliF.H.collab: TNT Steering"/>
  <result pre="Committee and InvestigatorsVisit-to-visit low-density lipoprotein cholesterol variability and risk of" exact="cardiovascular" post="outcomes: insights from the TNT trialJ Am Coll Cardiol6520151539154825881936"/>
 </snippets>
</snippetsTree>
